Entering text into the input field will update the search result below

Amgen, Inc. (AMGN) Presents at Goldman Sachs Healthcare Conference (Transcript)

Jun. 10, 2020 5:57 PM ETAmgen Inc. (AMGN) Stock
SA Transcripts profile picture
SA Transcripts

Amgen, Inc. (NASDAQ:AMGN) Goldman Sachs Healthcare Conference Call June 10, 2020 1:20 PM ET

Company Participants

Peter Griffith - EVP and CFO

Dave Reese - EVP and Head of R&D

Arvind Sood - VP and Head, IR

Conference Call Participants

Terence Flynn - Goldman Sachs

Terence Flynn

Great. Good afternoon, everybody. I'm Terence Flynn, the biopharma analyst at Goldman Sachs. We're very pleased to welcome Amgen. Joining us today from the Company we have Peter Griffith, who is Executive Vice President and CFO, Dave Reese, who is Executive Vice President and Head of R&D, and Arvind Sood, who is Vice President and Head of Investor Relations. Thank you very much gentlemen for joining us today. We really appreciate your time.

And so, first, I'm going to turn it over to Peter and Dave to make some opening remarks before we launch into questions.

Peter Griffith

Terence, thank you very much and thank you to Goldman Sachs.

In the midst of the unprecedented COVID-19 pandemic, our focus remains on the safety of our employees and their families and continuing to reliably supply our medicines to patients across the globe.

Dave and I, led by our CEO, Bob Bradway reached out to any number of our employees regarding the current climate in the United States on race relations, and we stressed that this is not a time for silence, and Amgen will continue to work across our organization and communities to seek concrete actions to address the inequality faced by people of color in our society today. And I would commend Goldman Sachs, Terrance, for your standards that you’ve set around Board members and IPOs recently that's received a lot of very important and very meaningful press.

Now, turning back to COVID-19, although we're going to absorb the impact of some business disruption, our business

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About AMGN Stock

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on AMGN

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.